首页 > 最新文献

Facts Views and Vision in ObGyn最新文献

英文 中文
Hysteroscopic removal of a retained intrauterine foreign body: a step-by-step technique. 宫腔镜下去除残留的宫内异物:一步一步的技术。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-08 DOI: 10.52054/FVVO.2025.120
Emma Bonetti Palermo, Federica Campolo, Eleonora La Fera, Federica Bernardini, Federico Ferrari, Franco Odicino, Ursula Catena

Background: Retained intrauterine foreign bodies are rare but may cause abnormal uterine bleeding (AUB) and pelvic pain. Hysteroscopy is the preferred approach for diagnosis and management.

Objectives: This video describes a step-by-step hysteroscopic technique for intrauterine foreign body removal.

Participant: A 60-year-old woman presented with pelvic pain and AUB. She underwent resectoscopic polypectomy three years before. A computed tomography scan revealed a cylindrical foreign body (12x8 millimetres) in the uterine cavity. The patient was referred to the Digital Hysteroscopic Clinic CLASS Hysteroscopy in Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, where she was scheduled for a minimally invasive hysteroscopic procedure.

Intervention: Hysteroscopic evaluation identified a tubular foreign body firmly adherent to the posterior uterine wall. Removal was performed using a hysteroscopic approach combined with a traction suture technique. First, 5 Fr scissors were used to detach the foreign body from the posterior uterine wall. Then, a Collins electrode of a 15 Fr bipolar miniresectoscope was employed to incise the lateral isthmic walls to facilitate extraction. Finally, a 0 Vicryl traction suture loop, inserted through the foreign body using 5 Fr grasping forceps, enabled controlled removal under hysteroscopic guidance. The foreign body was successfully extracted.

Conclusions: This video demonstrates a step-by-step hysteroscopic technique for intrauterine foreign body removal, highlighting the safety and precision of this minimally invasive approach.

What is new?: This is the first reported case of hysteroscopic removal of a retained intrauterine foreign body, using a traction suture technique under hysteroscopic guidance for a controlled extraction.

背景:保留的宫内异物是罕见的,但可能导致异常子宫出血(AUB)和盆腔疼痛。宫腔镜是诊断和治疗的首选方法。目的:本视频介绍宫腔镜一步一步宫内异物清除术。参与者:一名60岁女性,表现为盆腔疼痛和AUB。三年前,她接受了息肉切除术。计算机断层扫描显示子宫腔内有一个圆柱形异物(12 x 8毫米)。患者被转介到罗马的Fondazione Policlinico Universitario a . Gemelli IRCCS的数字宫腔镜临床级宫腔镜,在那里她被安排进行微创宫腔镜手术。干预:宫腔镜检查发现一管状异物牢固附着于子宫后壁。采用宫腔镜结合牵引缝合技术切除。首先,使用5fr剪刀将异物从子宫后壁分离。然后,使用15fr双极微型切除镜的柯林斯电极切开峡侧壁以方便取出。最后,使用5fr钳将0 Vicryl牵引缝合环穿过异物,在宫腔镜引导下进行可控取出。异物被成功取出。结论:本视频演示了宫腔镜一步一步宫内异物取出技术,强调了这种微创方法的安全性和精确性。有什么新鲜事吗?这是第一例宫腔镜下宫内异物取出术的报道,在宫腔镜指导下,采用牵引缝合技术进行控制取出。
{"title":"Hysteroscopic removal of a retained intrauterine foreign body: a step-by-step technique.","authors":"Emma Bonetti Palermo, Federica Campolo, Eleonora La Fera, Federica Bernardini, Federico Ferrari, Franco Odicino, Ursula Catena","doi":"10.52054/FVVO.2025.120","DOIUrl":"10.52054/FVVO.2025.120","url":null,"abstract":"<p><strong>Background: </strong>Retained intrauterine foreign bodies are rare but may cause abnormal uterine bleeding (AUB) and pelvic pain. Hysteroscopy is the preferred approach for diagnosis and management.</p><p><strong>Objectives: </strong>This video describes a step-by-step hysteroscopic technique for intrauterine foreign body removal.</p><p><strong>Participant: </strong>A 60-year-old woman presented with pelvic pain and AUB. She underwent resectoscopic polypectomy three years before. A computed tomography scan revealed a cylindrical foreign body (12x8 millimetres) in the uterine cavity. The patient was referred to the Digital Hysteroscopic Clinic CLASS Hysteroscopy in Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, where she was scheduled for a minimally invasive hysteroscopic procedure.</p><p><strong>Intervention: </strong>Hysteroscopic evaluation identified a tubular foreign body firmly adherent to the posterior uterine wall. Removal was performed using a hysteroscopic approach combined with a traction suture technique. First, 5 Fr scissors were used to detach the foreign body from the posterior uterine wall. Then, a Collins electrode of a 15 Fr bipolar miniresectoscope was employed to incise the lateral isthmic walls to facilitate extraction. Finally, a 0 Vicryl traction suture loop, inserted through the foreign body using 5 Fr grasping forceps, enabled controlled removal under hysteroscopic guidance. The foreign body was successfully extracted.</p><p><strong>Conclusions: </strong>This video demonstrates a step-by-step hysteroscopic technique for intrauterine foreign body removal, highlighting the safety and precision of this minimally invasive approach.</p><p><strong>What is new?: </strong>This is the first reported case of hysteroscopic removal of a retained intrauterine foreign body, using a traction suture technique under hysteroscopic guidance for a controlled extraction.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"413-414"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and early outcomes of robotic sacrocolpopexy with the Versius® platform: a prospective single-centre experience. 使用Versius®平台进行机器人骶髂关节固定术的可行性和早期结果:一种前瞻性的单中心体验。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-15 DOI: 10.52054/FVVO.2025.223
Giovanni Panico, Davide Arrigo, Camilla Riccetti, Sara Mastrovito, Alfredo Ercoli, Anna Fagotti, Francesco Fanfani

Minimally invasive sacrocolpopexy is considered the reference procedure for pelvic organ prolapse (POP). This study reports the first series of robotic sacrocolpopexy (RSCP) performed with the Versius® Robotic Surgical System (CMR Surgical, Cambridge, UK). Twenty women with symptomatic multicompartment POP underwent nerve-sparing RSCP. All procedures were completed successfully with no complications or conversions. Surgical and functional outcomes were consistent with those reported for other minimally invasive techniques. At three-month follow-up, complete anatomical correction was achieved in 90% of patients, with improvement in patient-reported outcomes. Our experience indicates that the Versius® system is a safe and practical option for RSCP.

微创骶colpop固定术被认为是盆腔器官脱垂(POP)的参考手术。本研究报道了使用Versius®机器人手术系统(CMR Surgical, Cambridge, UK)进行的第一系列机器人骶colpopexy (RSCP)手术。20名有症状的多室POP的女性接受了保留神经的RSCP。所有手术均顺利完成,无并发症发生。手术和功能结果与其他微创技术的报道一致。在三个月的随访中,90%的患者实现了完全的解剖矫正,患者报告的结果有所改善。我们的经验表明,Versius®系统是一种安全实用的RSCP选择。
{"title":"Feasibility and early outcomes of robotic sacrocolpopexy with the Versius<sup>®</sup> platform: a prospective single-centre experience.","authors":"Giovanni Panico, Davide Arrigo, Camilla Riccetti, Sara Mastrovito, Alfredo Ercoli, Anna Fagotti, Francesco Fanfani","doi":"10.52054/FVVO.2025.223","DOIUrl":"10.52054/FVVO.2025.223","url":null,"abstract":"<p><p>Minimally invasive sacrocolpopexy is considered the reference procedure for pelvic organ prolapse (POP). This study reports the first series of robotic sacrocolpopexy (RSCP) performed with the Versius<sup>®</sup> Robotic Surgical System (CMR Surgical, Cambridge, UK). Twenty women with symptomatic multicompartment POP underwent nerve-sparing RSCP. All procedures were completed successfully with no complications or conversions. Surgical and functional outcomes were consistent with those reported for other minimally invasive techniques. At three-month follow-up, complete anatomical correction was achieved in 90% of patients, with improvement in patient-reported outcomes. Our experience indicates that the Versius<sup>®</sup> system is a safe and practical option for RSCP.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"363-368"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic-assisted hysterectomy using DEXTER®: the first prospective multicentre study. 机器人辅助子宫切除术使用DEXTER®:第一个前瞻性多中心研究。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-09 DOI: 10.52054/FVVO.2025.203
Sara Imboden, Chahin Achtari, Jérôme Léderrey, Marie-Lucile Bodet, Damien Emeriau, Ibrahim Alkatout, Nicolai Maass, Michael D Mueller

Background: Minimally invasive hysterectomy is increasingly performed robotically as new systems expand options and address limitations of traditional platforms, including financial, infrastructure, and workflow demands. The DEXTER® Robotic Surgery System was designed to address some of these challenges.

Objectives: To confirm perioperative and early postoperative safety, and evaluate the clinical performance of DEXTER in hysterectomy.

Methods: This prospective multicentre study included 34 patients who underwent robotic-assisted hysterectomy for benign or low-risk malignant diseases between November 2022 and November 2023. DEXTER was integrated into the surgical workflows of the four participating centres, which used their existing laparoscopic towers.

Main outcome measures: Primary outcomes were procedural conversions and Clavien-Dindo grade III-V events up to 30 days post-surgery.

Results: Median patient age was 45.5 years; median body mass index was 26.0 kg/m2. There were no conversions to laparotomy, intraoperative complications or transfusions, with a median estimated blood loss of 100 mL. Median skin-to-skin operative time was 125.5 min, including a median docking time of 5 minutes. Median length of hospitalisation was 2 days. Two Clavien-Dindo grade IIIb adverse events were recorded, neither of which was device-related. In 3 cases, the surgeons decided to finish the procedure laparoscopically.

Conclusions: Hysterectomy assisted with DEXTER can be safely performed even in the early learning phase. DEXTER facilitated an adaptable OR workflow allowing greater flexibility in procedural approaches. Further investigation with a larger cohort and a longer follow-up is required to evaluate long-term outcomes.

What is new?: First prospective multicentre study to confirm robotic-assisted hysterectomy using DEXTER is a feasible and safe approach for treating benign and low-risk malignant conditions.

背景:随着新系统扩大了选择范围,解决了传统平台的局限性,包括财务、基础设施和工作流程需求,微创子宫切除术越来越多地由机器人进行。DEXTER®机器人手术系统旨在解决其中的一些挑战。目的:确认DEXTER在子宫切除术中的围手术期及术后早期安全性,评价DEXTER在子宫切除术中的临床应用价值。方法:这项前瞻性多中心研究纳入了34例在2022年11月至2023年11月期间因良性或低风险恶性疾病接受机器人辅助子宫切除术的患者。DEXTER被整合到四个参与中心的手术工作流程中,这些中心使用他们现有的腹腔镜塔。主要结局指标:主要结局是手术后30天的手术转化和Clavien-Dindo III-V级事件。结果:患者中位年龄为45.5岁;中位体重指数为26.0 kg/m2。无中转开腹、术中并发症或输血,估计中位失血量为100 mL。皮对皮手术中位时间为125.5 min,其中中位对接时间为5分钟。中位住院时间为2天。记录了2例Clavien-Dindo IIIb级不良事件,均与器械无关。在3例中,外科医生决定在腹腔镜下完成手术。结论:子宫切除术辅助DEXTER可以安全地进行,即使在早期学习阶段。DEXTER促进了适应性强的OR工作流程,允许在程序方法上具有更大的灵活性。需要进一步的调查,更大的队列和更长的随访来评估长期结果。有什么新鲜事吗?:首个前瞻性多中心研究证实机器人辅助子宫切除术使用DEXTER是治疗良性和低风险恶性疾病的可行和安全的方法。
{"title":"Robotic-assisted hysterectomy using DEXTER<sup>®</sup>: the first prospective multicentre study.","authors":"Sara Imboden, Chahin Achtari, Jérôme Léderrey, Marie-Lucile Bodet, Damien Emeriau, Ibrahim Alkatout, Nicolai Maass, Michael D Mueller","doi":"10.52054/FVVO.2025.203","DOIUrl":"10.52054/FVVO.2025.203","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive hysterectomy is increasingly performed robotically as new systems expand options and address limitations of traditional platforms, including financial, infrastructure, and workflow demands. The DEXTER<sup>®</sup> Robotic Surgery System was designed to address some of these challenges.</p><p><strong>Objectives: </strong>To confirm perioperative and early postoperative safety, and evaluate the clinical performance of DEXTER in hysterectomy.</p><p><strong>Methods: </strong>This prospective multicentre study included 34 patients who underwent robotic-assisted hysterectomy for benign or low-risk malignant diseases between November 2022 and November 2023. DEXTER was integrated into the surgical workflows of the four participating centres, which used their existing laparoscopic towers.</p><p><strong>Main outcome measures: </strong>Primary outcomes were procedural conversions and Clavien-Dindo grade III-V events up to 30 days post-surgery.</p><p><strong>Results: </strong>Median patient age was 45.5 years; median body mass index was 26.0 kg/m<sup>2</sup>. There were no conversions to laparotomy, intraoperative complications or transfusions, with a median estimated blood loss of 100 mL. Median skin-to-skin operative time was 125.5 min, including a median docking time of 5 minutes. Median length of hospitalisation was 2 days. Two Clavien-Dindo grade IIIb adverse events were recorded, neither of which was device-related. In 3 cases, the surgeons decided to finish the procedure laparoscopically.</p><p><strong>Conclusions: </strong>Hysterectomy assisted with DEXTER can be safely performed even in the early learning phase. DEXTER facilitated an adaptable OR workflow allowing greater flexibility in procedural approaches. Further investigation with a larger cohort and a longer follow-up is required to evaluate long-term outcomes.</p><p><strong>What is new?: </strong>First prospective multicentre study to confirm robotic-assisted hysterectomy using DEXTER is a feasible and safe approach for treating benign and low-risk malignant conditions.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"329-337"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145709829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light at the end of the tunnel: design, implementation and outcomes of a pelvic pain management programme. 隧道尽头的光明:骨盆疼痛管理方案的设计、实施和结果。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-15 DOI: 10.52054/FVVO.2025.34
Gemma Bentham, Kelly Paull, Jessica Preshaw

Background: Chronic pelvic pain (CPP) is a complex, prevalent condition that significantly impacts quality of life, work, relationships, and healthcare resources. Management remains challenging, with variation in practice and no national consensus. Evidence supports a multidisciplinary approach to treatment.

Objectives: To describe the design, implementation, and outcomes of a multidisciplinary Pelvic Pain Management Programme (PPMP), reporting results from four programme cycles.

Methods: The PPMP was developed using behaviour-change principles and delivered over 12 weekly sessions. Participants completed validated psychometric questionnaires at baseline, programme completion, and 3-month follow-up. Change was analysed using repeated-measures ANOVA and clinical significance assessed using the Minimal Clinically Important Difference or the Reliable Change Index.

Main outcome measures: Psychometric questionnaires assessed the following outcome measures: pain intensity, pain self-efficacy, kinesiophobia, anxiety, depression, patient activation, health-related quality of life, pain acceptance, and catastrophising.

Results: Thirty-three participants completed the programme, with 19 full datasets. A statistically significant improvement was recorded across all measures, except for anxiety. At the 3-month follow-up, 79% of participants reported a clinically significant improvement in several areas. Notably, 82% of participants showed clinically significant improvement in pain self-efficacy, 74% in depression, and 81% in pain catastrophising at programme completion.

Conclusions: A PPMP is feasible, acceptable, and associated with significant and sustained improvements across biopsychosocial outcomes. Tailored PMPs may address gaps in CPP care and support long-term recovery.

What is new?: This represents the largest published dataset evaluating a PPMP. These results highlight the potential of PPMPs to achieve pain reduction and sustainable improvement in quality of life for individuals with CPP.

背景:慢性盆腔疼痛(CPP)是一种复杂的、普遍的疾病,显著影响生活质量、工作、人际关系和医疗资源。管理仍然具有挑战性,实践中存在差异,没有全国共识。证据支持多学科治疗方法。目的:描述多学科骨盆疼痛管理方案(PPMP)的设计、实施和结果,报告四个方案周期的结果。方法:PPMP采用行为改变原则制定,每周12次。参与者在基线、项目完成和3个月随访时完成了有效的心理测量问卷。使用重复测量方差分析分析变化,使用最小临床重要差异或可靠变化指数评估临床意义。主要结果测量:心理测量问卷评估了以下结果测量:疼痛强度、疼痛自我效能、运动恐惧症、焦虑、抑郁、患者激活、健康相关生活质量、疼痛接受度和灾难化。结果:33名参与者完成了项目,有19个完整的数据集。除焦虑外,所有测量都有统计学上的显著改善。在3个月的随访中,79%的参与者报告了几个领域的临床显着改善。值得注意的是,82%的参与者在疼痛自我效能方面表现出临床显著的改善,74%的参与者在抑郁方面表现出显著的改善,81%的参与者在项目完成时表现出疼痛灾难性的改善。结论:PPMP是可行的,可接受的,并且与生物心理社会结果的显著和持续改善有关。量身定制的pmp可以解决CPP护理方面的差距,并支持长期康复。有什么新鲜事吗?:这代表了评估PPMP的最大的已发表数据集。这些结果强调了PPMPs在减轻疼痛和持续改善CPP患者生活质量方面的潜力。
{"title":"Light at the end of the tunnel: design, implementation and outcomes of a pelvic pain management programme.","authors":"Gemma Bentham, Kelly Paull, Jessica Preshaw","doi":"10.52054/FVVO.2025.34","DOIUrl":"10.52054/FVVO.2025.34","url":null,"abstract":"<p><strong>Background: </strong>Chronic pelvic pain (CPP) is a complex, prevalent condition that significantly impacts quality of life, work, relationships, and healthcare resources. Management remains challenging, with variation in practice and no national consensus. Evidence supports a multidisciplinary approach to treatment.</p><p><strong>Objectives: </strong>To describe the design, implementation, and outcomes of a multidisciplinary Pelvic Pain Management Programme (PPMP), reporting results from four programme cycles.</p><p><strong>Methods: </strong>The PPMP was developed using behaviour-change principles and delivered over 12 weekly sessions. Participants completed validated psychometric questionnaires at baseline, programme completion, and 3-month follow-up. Change was analysed using repeated-measures ANOVA and clinical significance assessed using the Minimal Clinically Important Difference or the Reliable Change Index.</p><p><strong>Main outcome measures: </strong>Psychometric questionnaires assessed the following outcome measures: pain intensity, pain self-efficacy, kinesiophobia, anxiety, depression, patient activation, health-related quality of life, pain acceptance, and catastrophising.</p><p><strong>Results: </strong>Thirty-three participants completed the programme, with 19 full datasets. A statistically significant improvement was recorded across all measures, except for anxiety. At the 3-month follow-up, 79% of participants reported a clinically significant improvement in several areas. Notably, 82% of participants showed clinically significant improvement in pain self-efficacy, 74% in depression, and 81% in pain catastrophising at programme completion.</p><p><strong>Conclusions: </strong>A PPMP is feasible, acceptable, and associated with significant and sustained improvements across biopsychosocial outcomes. Tailored PMPs may address gaps in CPP care and support long-term recovery.</p><p><strong>What is new?: </strong>This represents the largest published dataset evaluating a PPMP. These results highlight the potential of PPMPs to achieve pain reduction and sustainable improvement in quality of life for individuals with CPP.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"338-348"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptions of endometriosis surgery on TikTok: quality and implications for patient counselling. TikTok上对子宫内膜异位症手术的看法:质量和对患者咨询的影响。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-19 DOI: 10.52054/FVVO.2025.198
Jaya Prakash, Amber T Lalla, Andrea Pelletier, Golnaz Namazi

Background: TikTok is a popular platform for sharing health experiences, including those related to endometriosis. However, the quality and tone of the surgical information shared remain unclear.

Objectives: To characterise TikTok content regarding perceptions of surgical management for endometriosis and analyse content for information quality and differences between healthcare professionals and patients.

Methods: A cross-sectional analysis of the top 100 most-viewed TikTok videos under the search term "endometriosis surgery" was conducted on September 22, 2024. Videos were included if in English, referenced "endometriosis," and mentioned "surgery," "operation," or "laparoscopy." Two independent reviewers assessed creator identity, tone, and content. The brief DISCERN tool evaluated information quality.

Main outcome measures: Primary outcomes included the perceived benefits and drawbacks of surgery, tone towards surgical intervention, and thematic content. Secondary outcomes included DISCERN scores and comparison of content across creator identities.

Results: Of the included videos (2021-2024), 80% were created by patients. Most conveyed a neutral tone (41%) towards surgery. Perceived benefits included therapeutic effects (68%) and diagnostic clarity (61%). Reported drawbacks were postoperative recovery (58%) and symptom persistence (22%). Common themes among patients included barriers to surgery (35%), medical gaslighting (30%), delayed diagnosis/misdiagnosis (25%), and inadequate presurgical counselling (20%). Median DISCERN scores were significantly lower for patient videos (1.00) vs. healthcare professionals (1.96; P<0.001).

Conclusions: TikTok content on endometriosis surgery is largely driven by patient narratives that highlight both hope and frustration. The low quality of information underscores the need for accessible, evidence-based educational content. Our findings represent a cross-sectional snapshot subject to algorithmic ranking and platform dynamics.

What is new?: This is the first study to systematically evaluate TikTok content focused on surgical management of endometriosis, demonstrating that patient-generated videos overwhelmingly drive the conversation. While patients frequently describe benefits such as diagnostic clarity and symptom relief, they also highlight barriers to surgery, postoperative challenges, recurrent symptoms, and experiences of medical gaslighting. Patient-created videos had significantly lower information quality than provider-generated content, underscoring a critical gap in evidence-based surgical education on social media and an opportunity for clinician engagement.

背景:TikTok是一个分享健康经验的热门平台,包括与子宫内膜异位症相关的经验。然而,所分享的手术信息的质量和语气仍不清楚。目的:描述TikTok内容对子宫内膜异位症手术治疗的看法,并分析内容的信息质量以及医疗保健专业人员和患者之间的差异。方法:对2024年9月22日搜索“子宫内膜异位症手术”的前100个观看量最高的TikTok视频进行横断面分析。视频包含英文版本,提到了“子宫内膜异位症”,并提到了“手术”、“手术”或“腹腔镜检查”。两名独立评审员评估了创作者的身份、语气和内容。简要的DISCERN工具评估信息质量。主要结局指标:主要结局包括手术的利弊、对手术干预的态度和主题内容。次要结果包括辨别分数和创作者身份之间的内容比较。结果:在纳入的视频(2021-2024)中,80%由患者制作。大多数人(41%)对手术持中立态度。感知的益处包括治疗效果(68%)和诊断清晰度(61%)。报告的缺点是术后恢复(58%)和症状持续(22%)。患者中常见的主题包括手术障碍(35%)、医疗煤气灯(30%)、延迟诊断/误诊(25%)和术前咨询不足(20%)。患者视频的中位数(1.00)明显低于医疗专业人员(1.96)。结论:TikTok关于子宫内膜异位症手术的内容在很大程度上是由强调希望和沮丧的患者叙述驱动的。信息的低质量突出表明需要提供可获取的、以证据为基础的教育内容。我们的研究结果代表了受算法排名和平台动态影响的横截面快照。有什么新鲜事吗?这是第一个系统评估TikTok内容的研究,重点是子宫内膜异位症的手术治疗,表明患者制作的视频在很大程度上推动了对话。虽然患者经常描述诸如诊断清晰度和症状缓解等益处,但他们也强调了手术障碍、术后挑战、复发症状和医疗煤气灯的经历。患者制作的视频的信息质量明显低于提供者生成的内容,这突显了社交媒体上循证外科教育的严重差距,以及临床医生参与的机会。
{"title":"Perceptions of endometriosis surgery on TikTok: quality and implications for patient counselling.","authors":"Jaya Prakash, Amber T Lalla, Andrea Pelletier, Golnaz Namazi","doi":"10.52054/FVVO.2025.198","DOIUrl":"10.52054/FVVO.2025.198","url":null,"abstract":"<p><strong>Background: </strong>TikTok is a popular platform for sharing health experiences, including those related to endometriosis. However, the quality and tone of the surgical information shared remain unclear.</p><p><strong>Objectives: </strong>To characterise TikTok content regarding perceptions of surgical management for endometriosis and analyse content for information quality and differences between healthcare professionals and patients.</p><p><strong>Methods: </strong>A cross-sectional analysis of the top 100 most-viewed TikTok videos under the search term \"endometriosis surgery\" was conducted on September 22, 2024. Videos were included if in English, referenced \"endometriosis,\" and mentioned \"surgery,\" \"operation,\" or \"laparoscopy.\" Two independent reviewers assessed creator identity, tone, and content. The brief DISCERN tool evaluated information quality.</p><p><strong>Main outcome measures: </strong>Primary outcomes included the perceived benefits and drawbacks of surgery, tone towards surgical intervention, and thematic content. Secondary outcomes included DISCERN scores and comparison of content across creator identities.</p><p><strong>Results: </strong>Of the included videos (2021-2024), 80% were created by patients. Most conveyed a neutral tone (41%) towards surgery. Perceived benefits included therapeutic effects (68%) and diagnostic clarity (61%). Reported drawbacks were postoperative recovery (58%) and symptom persistence (22%). Common themes among patients included barriers to surgery (35%), medical gaslighting (30%), delayed diagnosis/misdiagnosis (25%), and inadequate presurgical counselling (20%). Median DISCERN scores were significantly lower for patient videos (1.00) vs. healthcare professionals (1.96; <i>P</i><0.001).</p><p><strong>Conclusions: </strong>TikTok content on endometriosis surgery is largely driven by patient narratives that highlight both hope and frustration. The low quality of information underscores the need for accessible, evidence-based educational content. Our findings represent a cross-sectional snapshot subject to algorithmic ranking and platform dynamics.</p><p><strong>What is new?: </strong>This is the first study to systematically evaluate TikTok content focused on surgical management of endometriosis, demonstrating that patient-generated videos overwhelmingly drive the conversation. While patients frequently describe benefits such as diagnostic clarity and symptom relief, they also highlight barriers to surgery, postoperative challenges, recurrent symptoms, and experiences of medical gaslighting. Patient-created videos had significantly lower information quality than provider-generated content, underscoring a critical gap in evidence-based surgical education on social media and an opportunity for clinician engagement.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"349-355"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Iatrogenic breaching of the junctional zone: the unintended path to placenta accreta spectrum? 回复:医源性破坏结合带:无意路径到胎盘增生谱?
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-03 DOI: 10.52054/FVVO.2025.279.answer
Evy Gillet, Panayiotis Tanos, Helena Van Kerrebroeck, Stavros Karampelas, Marion Valkenburg, Istvan Argay, Alessa Sugihara, Stephan Gordts, Rudi Campo
{"title":"Reply: Iatrogenic breaching of the junctional zone: the unintended path to placenta accreta spectrum?","authors":"Evy Gillet, Panayiotis Tanos, Helena Van Kerrebroeck, Stavros Karampelas, Marion Valkenburg, Istvan Argay, Alessa Sugihara, Stephan Gordts, Rudi Campo","doi":"10.52054/FVVO.2025.279.answer","DOIUrl":"10.52054/FVVO.2025.279.answer","url":null,"abstract":"","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"417-418"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Da Vinci Single-Port surgery in an obese woman affected by endometrial cancer. 达芬奇单孔手术治疗患有子宫内膜癌的肥胖妇女。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-22 Epub Date: 2025-12-08 DOI: 10.52054/FVVO.2025.23
Benedetta Alberghetti, Elena Casetta, Antonell Biscione, Filippo M Capomacchia, James M Hughes, Riccardo Ponzone, Riccardo Oliva, Francesco Fanfani, Giovanni Scambia, Luigi C Turco
<p><strong>Background: </strong>Minimally invasive surgery in obese patients is advantageous in terms of postoperative recovery and estimated blood loss. In literature several retrospective studies comparing robot-assisted and laparoscopic surgery are present, while a randomised case-control study will better define the advantages prospectively.</p><p><strong>Objectives: </strong>Here we present the video of the surgical radical management for endometrial cancer in an obese woman using the Da Vinci Single-Port (SP) robotic platform.</p><p><strong>Participant: </strong>A 66-year-old woman with a body mass index (BMI) of 44 kg/m² and hypertension, diagnosed with grade 1 endometrioid endometrial cancer.</p><p><strong>Intervention: </strong>The patient underwent a SP Robotic assisted radical class a hysterectomy (as per the Querleu-Morrow classification), bilateral salpingo-oophorectomy and sentinel lymph-node biopsy. A 2.7 cm umbilical incision was performed, and the single port robotic trocar was easily positioned. A uterine manipulator was not employed; traction was achieved using vaginal valves. Due to her constitution, a pneumoperitoneum with an intra-abdominal pressure greater than 8 mmHg and a Trendelenburg inclination greater than 19° could not be achieved.</p><p><strong>Results: </strong>Docking time was 8 minutes, the console time was 84 minutes, and the total operation time was 128 minutes. The estimated blood loss was 200 mL. The pain scores were irrelevant. The duration of hospitalisation was 2 days. No perioperative early complications were recorded. The aesthetic result was good.</p><p><strong>Conclusions: </strong>To our knowledge, this is the first Da Vinci SP endometrial cancer treatment in an obese woman presented in a step-by-step video. Robotic surgeries were successfully performed, the triangulation of the instrument allowed for comfortable surgery. Therefore, this surgical system may also be applicable to patients with a high BMI; however, further studies are required to confirm these preliminary findings.</p><p><strong>What is new?: </strong>Minimally invasive surgery offers important benefits in terms of recovery, pain control, and reduced blood loss; however, its application in obese patients often remains challenging. The technical limitations imposed by body habitus-restricted working space, limited Trendelenburg positioning, and difficulties in trocar placement-can compromise both surgical exposure and oncologic radicality. In this context, the introduction of the Da Vinci SP robotic platform may represent a meaningful evolution in the management of this increasingly common patient population. The flexibility of the multi-jointed SP instruments and the ergonomic advantages of robotic control allow surgeons to overcome the typical restrictions encountered in this population. We believe that this report highlights an important step toward expanding the accessibility of minimally invasive radical surgery to all patients, reg
背景:微创手术在肥胖患者的术后恢复和估计出血量方面是有利的。在文献中,一些回顾性研究比较了机器人辅助手术和腹腔镜手术,而随机病例对照研究将更好地确定前瞻性优势。目的:在这里,我们展示了一段使用达芬奇单端口(SP)机器人平台对肥胖女性子宫内膜癌进行手术根治的视频。参与者:66岁女性,体重指数(BMI) 44 kg/m²,高血压,诊断为1级子宫内膜样子宫内膜癌。干预:患者接受了SP机器人辅助的根治性a级子宫切除术(按照Querleu-Morrow分类)、双侧输卵管卵巢切除术和前哨淋巴结活检。进行了2.7 cm的脐切口,单端口机器人套管针容易定位。未使用子宫操纵器;阴道瓣牵引。由于她的体质,腹内压大于8mmhg且Trendelenburg倾角大于19°的气腹无法实现。结果:对接时间8分钟,控制台时间84分钟,总手术时间128分钟。估计失血量为200毫升。疼痛评分无关紧要。住院时间为2天。无围手术期早期并发症记录。美学效果很好。结论:据我们所知,这是第一个在肥胖女性中逐步呈现的达芬奇SP子宫内膜癌治疗视频。机器人手术成功进行,仪器的三角测量允许舒适的手术。因此,该手术系统也可能适用于BMI较高的患者;然而,需要进一步的研究来证实这些初步发现。有什么新鲜事吗?微创手术在恢复、疼痛控制和减少失血方面提供了重要的好处;然而,它在肥胖患者中的应用仍然具有挑战性。身体习惯所带来的技术限制——工作空间受限、Trendelenburg定位受限、套管针置入困难——可能会危及手术暴露和肿瘤根瘤性。在这种情况下,达芬奇SP机器人平台的引入可能代表了这一日益常见的患者群体管理的有意义的演变。多关节SP器械的灵活性和机器人控制的人体工程学优势使外科医生能够克服在这一人群中遇到的典型限制。我们相信该报告强调了向所有患者扩大微创根治性手术可及性的重要一步,无论BMI如何。SP机器人方法结合了手术的激进性、患者的安全性和减少侵入性,为治疗肥胖女性子宫内膜癌提供了一种新的范例。
{"title":"Da Vinci Single-Port surgery in an obese woman affected by endometrial cancer.","authors":"Benedetta Alberghetti, Elena Casetta, Antonell Biscione, Filippo M Capomacchia, James M Hughes, Riccardo Ponzone, Riccardo Oliva, Francesco Fanfani, Giovanni Scambia, Luigi C Turco","doi":"10.52054/FVVO.2025.23","DOIUrl":"10.52054/FVVO.2025.23","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Minimally invasive surgery in obese patients is advantageous in terms of postoperative recovery and estimated blood loss. In literature several retrospective studies comparing robot-assisted and laparoscopic surgery are present, while a randomised case-control study will better define the advantages prospectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;Here we present the video of the surgical radical management for endometrial cancer in an obese woman using the Da Vinci Single-Port (SP) robotic platform.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Participant: &lt;/strong&gt;A 66-year-old woman with a body mass index (BMI) of 44 kg/m² and hypertension, diagnosed with grade 1 endometrioid endometrial cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Intervention: &lt;/strong&gt;The patient underwent a SP Robotic assisted radical class a hysterectomy (as per the Querleu-Morrow classification), bilateral salpingo-oophorectomy and sentinel lymph-node biopsy. A 2.7 cm umbilical incision was performed, and the single port robotic trocar was easily positioned. A uterine manipulator was not employed; traction was achieved using vaginal valves. Due to her constitution, a pneumoperitoneum with an intra-abdominal pressure greater than 8 mmHg and a Trendelenburg inclination greater than 19° could not be achieved.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Docking time was 8 minutes, the console time was 84 minutes, and the total operation time was 128 minutes. The estimated blood loss was 200 mL. The pain scores were irrelevant. The duration of hospitalisation was 2 days. No perioperative early complications were recorded. The aesthetic result was good.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;To our knowledge, this is the first Da Vinci SP endometrial cancer treatment in an obese woman presented in a step-by-step video. Robotic surgeries were successfully performed, the triangulation of the instrument allowed for comfortable surgery. Therefore, this surgical system may also be applicable to patients with a high BMI; however, further studies are required to confirm these preliminary findings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is new?: &lt;/strong&gt;Minimally invasive surgery offers important benefits in terms of recovery, pain control, and reduced blood loss; however, its application in obese patients often remains challenging. The technical limitations imposed by body habitus-restricted working space, limited Trendelenburg positioning, and difficulties in trocar placement-can compromise both surgical exposure and oncologic radicality. In this context, the introduction of the Da Vinci SP robotic platform may represent a meaningful evolution in the management of this increasingly common patient population. The flexibility of the multi-jointed SP instruments and the ergonomic advantages of robotic control allow surgeons to overcome the typical restrictions encountered in this population. We believe that this report highlights an important step toward expanding the accessibility of minimally invasive radical surgery to all patients, reg","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"407-408"},"PeriodicalIF":1.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12721460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of pre-operative gonadotrophin-releasing hormone agonists (GnRHa) on pain, bowel and bladder symptoms in rectovaginal/colorectal endometriosis surgery: a multicenter cohort study. 术前促性腺激素释放激素激动剂(GnRHa)对直肠阴道/结直肠子宫内膜异位症手术中疼痛、肠和膀胱症状的作用:一项多中心队列研究
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-30 Epub Date: 2025-09-23 DOI: 10.52054/FVVO.2025.39
Munazzah Rafique, Christian Becker, Jonathan Lewin, Arvind Vashisht, Ertan Sarıdoğan, Martin Hirsch
<p><strong>Background: </strong>The efficacy of medical and surgical treatment of endometriosis-associated pain is a source of ongoing controversy. There is a lack of evidence about gonadotropin-releasing hormone agonists (GnRHa) use on long-term pain control, bladder and bowel symptoms for patients having surgery for deep rectovaginal/colorectal endometriosis.</p><p><strong>Objectives: </strong>To assess the effect of preoperative GnRHa (pre-GnRHa) use on pain, bowel and bladder symptoms for patients undergoing surgery for deep rectovaginal/colorectal endometriosis.</p><p><strong>Methods: </strong>The study evaluated data from the British Society for Gynaecological Endoscopy database, a large international multicentre prospective cohort of patients who underwent deep rectovaginal/colorectal endometriosis surgery between 2009-2021. We included 9433 patients from 101 accredited endometriosis centres. Multivariable logistic regression analysis was used to evaluate the association between pre-GnRHa use and postoperative pain, bowel and bladder symptoms at different time points, controlling for confounders like patient age, body mass index, smoking status, and hysterectomy.</p><p><strong>Main outcome measures: </strong>Rate of cyclical and non-cyclical pelvic and menstrual pain, bowel and bladder symptoms.</p><p><strong>Results: </strong>The mean age of the patients was 36 years (18-55). Pre-GnRHa use was associated with significant postoperative improvement in premenstrual pain [odds ratio (OR): 0.30, 95% confidence interval (CI): -0.57 - -0.034, <i>P</i>=0.02*], menstrual pain (OR: 0.41/10, 95% CI: -0.7 - -0.13, <i>P</i>=<0.001*), non-cyclical pain (OR: 0.27/10, 95% CI: -0.5 - -0.04, <i>P</i>=0.021*) and lower backache (OR: 0.30, 95% CI: -0.532 - -0.087, <i>P</i>=0.006*) up to 12 months postoperatively. Moreover, bladder pain was significantly reduced in the pre-GnRHa group at 12 months (OR: 0.24, 95% CI: -0.451 - -0.039, <i>P</i>=0.01*). Significant improvements were observed in bowel symptoms including frequent bowel movements (OR: 0.10, 95% CI: -0.194 - -0.012, P=0.02*), incomplete emptying sensation (OR: 0.10, 95% CI: -0.196 - -0.023, <i>P</i>=0.01*), cyclical dyschezia (OR: 0.43, 95% CI: -0.724 - -0.142, <i>P</i>=0.003*) and non-cyclical dyschezia (OR: 0.28, 95% CI: -0.504 - -0.075, <i>P</i>=0.008*) up to 12 months.</p><p><strong>Conclusions: </strong>Pre-GnRHa use is associated with a significant reduction in postoperative menstrual pain and non-menstrual pain as well as improved bowel and bladder symptoms lasting up to two years. It is also valuable to improve the quality of life for patients undergoing surgery for deep rectovaginal/colorectal endometriosis.</p><p><strong>What is new?: </strong>This is the largest prospective international study evaluating pre-GnRHa use in deep rectovaginal/colorectal endometriosis surgery. It provides evidence supporting the role of pre-GnRHa as an adjuvant to surgical treatment, to reduce postoperative pai
背景:药物和手术治疗子宫内膜异位症相关疼痛的疗效是一个持续争议的来源。促性腺激素释放激素激动剂(GnRHa)用于直肠阴道/结直肠子宫内膜异位症手术患者的长期疼痛控制、膀胱和肠道症状缺乏证据。目的:评估术前使用GnRHa (pre-GnRHa)对深直肠阴道/结直肠子宫内膜异位症手术患者疼痛、肠道和膀胱症状的影响。方法:该研究评估了来自英国妇科内镜学会数据库的数据,该数据库是一个大型的国际多中心前瞻性队列,研究对象是2009-2021年间接受直肠阴道/结直肠子宫内膜异位症手术的患者。我们纳入了来自101个经认证的子宫内膜异位症中心的9433名患者。采用多变量logistic回归分析,在控制患者年龄、体重指数、吸烟状况和子宫切除术等混杂因素的情况下,评估gnrha术前使用与术后不同时间点疼痛、肠道和膀胱症状之间的关系。主要观察指标:周期性和非周期性骨盆和月经疼痛发生率、肠道和膀胱症状。结果:患者平均年龄36岁(18-55岁)。术前使用gnrha可显著改善术后12个月的经前疼痛[优势比(OR): 0.30, 95%可信区间(CI): -0.57 - -0.034, P=0.02*]、月经疼痛(OR: 0.41/10, 95% CI: -0.7 - -0.13, P=P=0.021*)和腰痛(OR: 0.30, 95% CI: -0.532 - -0.087, P=0.006*)。此外,gnrha前组在12个月时膀胱疼痛明显减轻(OR: 0.24, 95% CI: -0.451 - -0.039, P=0.01*)。观察到肠道症状的显著改善,包括频繁排便(OR: 0.10, 95% CI: -0.194 - -0.012, P=0.02*),不完全排空感(OR: 0.10, 95% CI: -0.196 - -0.023, P=0.01*),周期性排便障碍(OR: 0.43, 95% CI: -0.724 - -0.142, P=0.003*)和非周期性排便障碍(OR: 0.28, 95% CI: -0.504 - -0.075, P=0.008*)长达12个月。结论:术前使用gnrha与术后月经疼痛和非月经疼痛的显著减少以及肠道和膀胱症状的改善相关,持续时间长达两年。对于改善直肠阴道/结直肠深部子宫内膜异位症手术患者的生活质量也有价值。有什么新鲜事吗?这是评估gnrha在直肠阴道/结直肠子宫内膜异位症手术中应用的最大的前瞻性国际研究。它提供了证据支持前gnrha作为手术治疗的辅助作用,以减少术后疼痛和改善肠道和膀胱功能。
{"title":"The role of pre-operative gonadotrophin-releasing hormone agonists (GnRHa) on pain, bowel and bladder symptoms in rectovaginal/colorectal endometriosis surgery: a multicenter cohort study.","authors":"Munazzah Rafique, Christian Becker, Jonathan Lewin, Arvind Vashisht, Ertan Sarıdoğan, Martin Hirsch","doi":"10.52054/FVVO.2025.39","DOIUrl":"10.52054/FVVO.2025.39","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The efficacy of medical and surgical treatment of endometriosis-associated pain is a source of ongoing controversy. There is a lack of evidence about gonadotropin-releasing hormone agonists (GnRHa) use on long-term pain control, bladder and bowel symptoms for patients having surgery for deep rectovaginal/colorectal endometriosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To assess the effect of preoperative GnRHa (pre-GnRHa) use on pain, bowel and bladder symptoms for patients undergoing surgery for deep rectovaginal/colorectal endometriosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The study evaluated data from the British Society for Gynaecological Endoscopy database, a large international multicentre prospective cohort of patients who underwent deep rectovaginal/colorectal endometriosis surgery between 2009-2021. We included 9433 patients from 101 accredited endometriosis centres. Multivariable logistic regression analysis was used to evaluate the association between pre-GnRHa use and postoperative pain, bowel and bladder symptoms at different time points, controlling for confounders like patient age, body mass index, smoking status, and hysterectomy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;Rate of cyclical and non-cyclical pelvic and menstrual pain, bowel and bladder symptoms.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The mean age of the patients was 36 years (18-55). Pre-GnRHa use was associated with significant postoperative improvement in premenstrual pain [odds ratio (OR): 0.30, 95% confidence interval (CI): -0.57 - -0.034, &lt;i&gt;P&lt;/i&gt;=0.02*], menstrual pain (OR: 0.41/10, 95% CI: -0.7 - -0.13, &lt;i&gt;P&lt;/i&gt;=&lt;0.001*), non-cyclical pain (OR: 0.27/10, 95% CI: -0.5 - -0.04, &lt;i&gt;P&lt;/i&gt;=0.021*) and lower backache (OR: 0.30, 95% CI: -0.532 - -0.087, &lt;i&gt;P&lt;/i&gt;=0.006*) up to 12 months postoperatively. Moreover, bladder pain was significantly reduced in the pre-GnRHa group at 12 months (OR: 0.24, 95% CI: -0.451 - -0.039, &lt;i&gt;P&lt;/i&gt;=0.01*). Significant improvements were observed in bowel symptoms including frequent bowel movements (OR: 0.10, 95% CI: -0.194 - -0.012, P=0.02*), incomplete emptying sensation (OR: 0.10, 95% CI: -0.196 - -0.023, &lt;i&gt;P&lt;/i&gt;=0.01*), cyclical dyschezia (OR: 0.43, 95% CI: -0.724 - -0.142, &lt;i&gt;P&lt;/i&gt;=0.003*) and non-cyclical dyschezia (OR: 0.28, 95% CI: -0.504 - -0.075, &lt;i&gt;P&lt;/i&gt;=0.008*) up to 12 months.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Pre-GnRHa use is associated with a significant reduction in postoperative menstrual pain and non-menstrual pain as well as improved bowel and bladder symptoms lasting up to two years. It is also valuable to improve the quality of life for patients undergoing surgery for deep rectovaginal/colorectal endometriosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;What is new?: &lt;/strong&gt;This is the largest prospective international study evaluating pre-GnRHa use in deep rectovaginal/colorectal endometriosis surgery. It provides evidence supporting the role of pre-GnRHa as an adjuvant to surgical treatment, to reduce postoperative pai","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"222-231"},"PeriodicalIF":1.4,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145125821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The scientific gap. 科学差距。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-30 DOI: 10.52054/FVVO.2025.260925
Harald Krentel, Rudy Leon de Wilde, Maya Sophie de Wilde
{"title":"The scientific gap.","authors":"Harald Krentel, Rudy Leon de Wilde, Maya Sophie de Wilde","doi":"10.52054/FVVO.2025.260925","DOIUrl":"10.52054/FVVO.2025.260925","url":null,"abstract":"","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"17 3","pages":"216-217"},"PeriodicalIF":1.4,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145201782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Race and ethnicity reporting in endometriosis literature: a systematic review. 子宫内膜异位症文献中的种族和民族报告:系统回顾。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-30 DOI: 10.52054/FVVO.2025.153
Antonio Raffone, Marisol Doglioli, Alberto Aguzzi, Ludovica Girardi, Lucia De Meis, Daniele Neola, Antonio Travaglino, Matteo Giorgi, Maria Giovanna Vastarella, Luigi Cobellis, Renato Seracchioli, Diego Raimondo

Background: Accurate reporting of participants' race and ethnicity is essential for assessing the representativeness of study populations and for identifying potential disparities in diagnosis, treatment, and outcomes.

Objectives: To assess the quantity and quality of race and/or ethnicity reporting in the endometriosis literature.

Methods: A systematic review of all human studies reporting data about endometriosis as the primary objective published in 2022. Studies were identified from electronic searches of MEDLINE, Google Scholar, Web of Science, Scopus, ClinicalTrials.gov, and the Cochrane Library databases.

Main outcomes measures: The frequency and quality of participants' race and/or ethnicity reporting based on compliance with the guidelines set by the ICMJE. Study characteristics that influenced the reporting of race and/or ethnicity were assessed. Publications from journals that followed ICMJE recommendations were compared with those from journals that did not.

Results: 648/2054 (31.6%) articles met the inclusion criteria. Sixty-five studies (10.0%) reported participants' race and/or ethnicity, and the overall quality of this reporting was poor. The frequency of reporting did not differ between journals adhering to ICMJE guidelines and those that did not (24, 11% vs. 41, 9.5%; P=0.52), between studies involving national versus international populations (60, 92.3% vs. 5, 7.7%; P=0.28), or between male and female authors (33, 50.8% vs. 32, 49.2%; P=0.38) respectively. Race and/or ethnicity were reported more often in prospective than in retrospective studies (37, 56.9% vs. 18, 27.7%; P<0.001), and in multicentre compared to single-centre studies (44, 67.7% vs. 21, 32.3%; P<0.001).

Conclusions: The reporting of race and/or ethnicity in human-based endometriosis research remains both infrequent and inconsistent, including in journals claiming adherence to ICMJE standards. These results highlight the need for improved and uniform documentation of racial and ethnic data in endometriosis research.

What is new?: Human-based articles focusing on endometriosis have a low frequency and quality of race and/or ethnicity reporting, even in journals claiming to follow ICMJE recommendations.

背景:准确报告参与者的种族和民族对于评估研究人群的代表性和识别诊断、治疗和结果的潜在差异至关重要。目的:评估子宫内膜异位症文献中种族和/或民族报告的数量和质量。方法:对2022年发表的所有以子宫内膜异位症为主要目标的人类研究进行系统回顾。研究从MEDLINE、b谷歌Scholar、Web of Science、Scopus、ClinicalTrials.gov和Cochrane Library数据库的电子搜索中确定。主要结果测量:根据ICMJE制定的准则,参与者种族和/或民族报告的频率和质量。评估了影响种族和/或民族报告的研究特征。遵循ICMJE建议的期刊发表的文章与未遵循ICMJE建议的期刊发表的文章进行比较。结果:648/2054篇(31.6%)文章符合纳入标准。65项研究(10.0%)报告了参与者的种族和/或民族,报告的总体质量较差。在遵循ICMJE指南的期刊与未遵循ICMJE指南的期刊之间(24.11% vs. 41.9.5%, P=0.52),在涉及国内与国际人群的研究之间(60,92.3% vs. 5.7.7%, P=0.28),以及在男性和女性作者之间(33.50.8% vs. 32.49.2%, P=0.38),报告的频率均无差异。种族和/或民族在前瞻性研究中比在回顾性研究中更常被报道(37.56.9% vs. 18.27.7%)。pp结论:在基于人的子宫内膜异位症研究中,种族和/或民族的报道仍然是罕见和不一致的,包括在声称遵守ICMJE标准的期刊中。这些结果强调了在子宫内膜异位症研究中对种族和民族数据进行改进和统一记录的必要性。有什么新鲜事吗?关注子宫内膜异位症的基于人类的文章,即使在声称遵循ICMJE建议的期刊上,种族和/或民族报道的频率和质量也很低。
{"title":"Race and ethnicity reporting in endometriosis literature: a systematic review.","authors":"Antonio Raffone, Marisol Doglioli, Alberto Aguzzi, Ludovica Girardi, Lucia De Meis, Daniele Neola, Antonio Travaglino, Matteo Giorgi, Maria Giovanna Vastarella, Luigi Cobellis, Renato Seracchioli, Diego Raimondo","doi":"10.52054/FVVO.2025.153","DOIUrl":"10.52054/FVVO.2025.153","url":null,"abstract":"<p><strong>Background: </strong>Accurate reporting of participants' race and ethnicity is essential for assessing the representativeness of study populations and for identifying potential disparities in diagnosis, treatment, and outcomes.</p><p><strong>Objectives: </strong>To assess the quantity and quality of race and/or ethnicity reporting in the endometriosis literature.</p><p><strong>Methods: </strong>A systematic review of all human studies reporting data about endometriosis as the primary objective published in 2022. Studies were identified from electronic searches of MEDLINE, Google Scholar, Web of Science, Scopus, ClinicalTrials.gov, and the Cochrane Library databases.</p><p><strong>Main outcomes measures: </strong>The frequency and quality of participants' race and/or ethnicity reporting based on compliance with the guidelines set by the ICMJE. Study characteristics that influenced the reporting of race and/or ethnicity were assessed. Publications from journals that followed ICMJE recommendations were compared with those from journals that did not.</p><p><strong>Results: </strong>648/2054 (31.6%) articles met the inclusion criteria. Sixty-five studies (10.0%) reported participants' race and/or ethnicity, and the overall quality of this reporting was poor. The frequency of reporting did not differ between journals adhering to ICMJE guidelines and those that did not (24, 11% vs. 41, 9.5%; <i>P</i>=0.52), between studies involving national versus international populations (60, 92.3% vs. 5, 7.7%; <i>P</i>=0.28), or between male and female authors (33, 50.8% vs. 32, 49.2%; <i>P</i>=0.38) respectively. Race and/or ethnicity were reported more often in prospective than in retrospective studies (37, 56.9% vs. 18, 27.7%; <i>P</i><0.001), and in multicentre compared to single-centre studies (44, 67.7% vs. 21, 32.3%; <i>P</i><0.001).</p><p><strong>Conclusions: </strong>The reporting of race and/or ethnicity in human-based endometriosis research remains both infrequent and inconsistent, including in journals claiming adherence to ICMJE standards. These results highlight the need for improved and uniform documentation of racial and ethnic data in endometriosis research.</p><p><strong>What is new?: </strong>Human-based articles focusing on endometriosis have a low frequency and quality of race and/or ethnicity reporting, even in journals claiming to follow ICMJE recommendations.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"17 3","pages":"263-270"},"PeriodicalIF":1.4,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145201818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Facts Views and Vision in ObGyn
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1